Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151–210.

Article  Google Scholar 

Harjutsalo V, Thomas MC, Forsblom C, Groop P-H, FinnDiane Study Group. Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes. Diabetes Obes Metab. 2018;20:2759–67.

Article  CAS  PubMed  Google Scholar 

Wu L, Parhofer KG. Diabetic dyslipidemia. Metabolism. 2014;63:1469–79.

Article  CAS  PubMed  Google Scholar 

Tolonen N, Forsblom C, Mäkinen V-P, Harjutsalo V, Gordin D, Feodoroff M, et al. Different lipid variables predict incident coronary artery disease in patients with type 1 diabetes with or without diabetic nephropathy: the FinnDiane study. Diabetes Care. 2014;37:2374–82.

Article  CAS  PubMed  Google Scholar 

Tabassum R, Rämö JT, Ripatti P, Koskela JT, Kurki M, Karjalainen J, et al. Genetic architecture of human plasma lipidome and its link to cardiovascular disease. Nat Commun. 2019;10:4329.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klarin D, Damrauer SM, Cho K, Sun YV, Teslovich TM, Honerlaw J, et al. Genetics of blood lipids among 300,000 multi-ethnic participants of the Million Veteran Program. Nat Genet. 2018;50:1514–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Surakka I, Horikoshi M, Mägi R, Sarin A-P, Mahajan A, Lagou V, et al. The impact of low-frequency and rare variants on lipid levels. Nat Genet. 2015;47:589–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu DJ, Peloso GM, Yu H, Butterworth AS, Wang X, Mahajan A, et al. Exome-wide association study of plasma lipids in >300,000 individuals. Nat Genet. 2017;49:1758–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Backman JD, Li AH, Marcketta A, Sun D, Mbatchou J, Kessler MD, et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature. 2021;599:628–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science. 2012;337:1190–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sandholm N, Van Zuydam N, Ahlqvist E, Juliusdottir T, Deshmukh HA, Rayner NW, et al. The genetic landscape of renal complications in type 1 diabetes. J Am Soc Nephrol. 2017;28:557–74.

Article  PubMed  Google Scholar 

Sandholm N, Haukka JK, Toppila I, Valo E, Harjutsalo V, Forsblom C, et al. Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes. Sci Rep. 2018;8:12408.

Article  PubMed  PubMed Central  Google Scholar 

Hindy G, Dornbos P, Chaffin MD, Liu DJ, Wang M, Selvaraj MS, et al. Rare coding variants in 35 genes associate with circulating lipid levels-a multi-ancestry analysis of 170,000 exomes. Am J Hum Genet. 2022;109:81–96.

Article  CAS  PubMed  Google Scholar 

Cohen JC, Boerwinkle E, Mosley TH, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006;354:1264–72.

Article  CAS  PubMed  Google Scholar 

Stitziel NO, Peloso GM, Abifadel M, Cefalu AB, Fouchier S, Motazacker MM, et al. Exome sequencing in suspected monogenic dyslipidemias. Circ Cardiovasc Genet. 2015;8:343–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lange LA, Hu Y, Zhang H, Xue C, Schmidt EM, Tang Z-Z, et al. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am J Hum Genet. 2014;94:233–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tabassum R, Ripatti S. Integrating lipidomics and genomics: emerging tools to understand cardiovascular diseases. Cell Mol Life Sci. 2021;78:2565–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sniderman AD, Thanassoulis G, Glavinovic T, Navar AM, Pencina M, Catapano A, et al. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol. 2019;4:1287–95.

Article  PubMed  PubMed Central  Google Scholar 

Ohukainen P, Kuusisto S, Kettunen J, Perola M, Järvelin M-R, Mäkinen V-P, et al. Data-driven multivariate population subgrouping via lipoprotein phenotypes versus apolipoprotein B in the risk assessment of coronary heart disease. Atherosclerosis. 2020;294:10–5.

Article  CAS  PubMed  Google Scholar 

Kanter JE, Shao B, Kramer F, Barnhart S, Shimizu-Albergine M, Vaisar T, et al. Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes. J Clin Invest. 2019;129:4165–79.

Article  PubMed  PubMed Central  Google Scholar 

Taskinen M-R, Packard CJ, Borén J. Emerging evidence that ApoC-III inhibitors provide novel options to reduce the residual CVD. Curr Atheroscler Rep. 2019;21:27.

Article  PubMed  PubMed Central  Google Scholar 

Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G, et al. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis. PLoS Med. 2020;17:e1003062.

Article  PubMed  PubMed Central  Google Scholar 

Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG, Tybjærg-Hansen A. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. N Engl J Med. 2014;371:32–41.

Article  PubMed  Google Scholar 

Chen M, Breslow JL, Li W, Leff T. Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels. J Lipid Res. 1994;35:1918–24.

Article  CAS  PubMed  Google Scholar 

Caron S, Verrijken A, Mertens I, Samanez CH, Mautino G, Haas JT, et al. Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia. Arterioscler Thromb Vasc Biol. 2011;31:513–9.

Article  CAS  PubMed  Google Scholar 

Adiels M, Olofsson S-O, Taskinen M-R, Borén J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:1225–36.

Article  CAS  PubMed  Google Scholar 

Lim ET, Wurtz P, Havulinna AS, Palta P, Tukiainen T, Rehnstrom K, et al. Distribution and medical impact of loss-of-function variants in the Finnish founder population. PLoS Genet. 2014;10:e1004494.

Article  PubMed  PubMed Central  Google Scholar 

Lithovius R, Harjutsalo V, Mutter S, Gordin D, Forsblom C, Groop P-H, et al. Resistant hypertension and risk of adverse events in individuals with type 1 diabetes: a nationwide prospective study. Diabetes Care. 2020;43:1885–92.

Article  PubMed  Google Scholar 

Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, et al. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care. 2005;28:2019–24.

Article  PubMed  Google Scholar 

Syreeni A, Sandholm N, Cao J, Toppila I, Maahs DM, Rewers MJ, et al. Genetic determinants of glycated hemoglobin in type 1 diabetes. Diabetes. 2019;68:858–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salem RM, Todd JN, Sandholm N, Cole JB, Chen W-M, Andrews D, et al. Genome-wide association study of diabetic kidney disease highlights biology involved in glomerular basement membrane collagen. J Am Soc Nephrol. 2019;30:2000–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Graham SE, Clarke SL, Wu K-HH, Kanoni S, Zajac GJM, Ramdas S, et al. The power of genetic diversity in genome-wide association studies of lipids. Nature. 2021;600:675–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

FinnGen study. FinnGen GWAS result browser [Internet]. https://r7.finngen.fi. Accessed 27 June 2022.

Tolonen N, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Saraheimo M, et al. Relationship between lipid profiles and kidney function in patients with type 1 diabetes. Diabetologia. 2008;51:12–20.

Article  CAS  PubMed  Google Scholar 

Mäkinen V-P, Tynkkynen T, Soininen P, Peltola T, Kangas AJ, Forsblom C, et al. Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes (the FinnDiane Study). J Proteome Res. 2012;11:1782–90.

Article  PubMed  Google Scholar 

Mäkinen V-P, Soininen P, Kangas AJ, Forsblom C, Tolonen N, Thorn LM, et al. Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic